Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis
Journal Article
·
· Arch. Neurol.; (United States)
Regional cerebral glucose metabolism was studied in a 15-year-old boy with subacute sclerosing panencephalitis before and after therapy with human interferon beta, using positron emission tomography of fluorine 18-2-fluoro-2-deoxyglucose. At first examination, metabolism was symmetrically decreased in the thalamus, cerebellum, and all cortical areas except prerolandic motor cortex, but increased in lentiform nucleus. A computed tomographic scan was normal. Six months later, bilateral focal necrosis centered in the previously hypermetabolic putamen was demonstrated by computed tomography and magnetic resonance imaging. The caudate nucleus and the superoposterior part of the putamen were spared, still showing increased metabolism. Corresponding with some clinical improvement, cortical glucose consumption rates had returned to a normal level.
- Research Organization:
- Max-Planck-Institut fuer Neurologische Forschung, Cologne (West Germany)
- OSTI ID:
- 6406763
- Journal Information:
- Arch. Neurol.; (United States), Journal Name: Arch. Neurol.; (United States) Vol. 46:1; ISSN ARNEA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Increase of glucose consumption in basal ganglia, thalamus and frontal cortex of patients with spasmodic torticollis
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography
Cerebral metabolism of glucose in benign hereditary chorea
Journal Article
·
Sun May 01 00:00:00 EDT 1994
· Journal of Nuclear Medicine
·
OSTI ID:197974
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography
Journal Article
·
Thu Sep 01 00:00:00 EDT 1988
· Ann. Neurol.; (United States)
·
OSTI ID:6326347
Cerebral metabolism of glucose in benign hereditary chorea
Journal Article
·
Tue Dec 31 23:00:00 EST 1985
· Mov. Disord.; (United States)
·
OSTI ID:6514242
Related Subjects
550600 -- Medicine
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ALDEHYDES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
BRAIN
CARBOHYDRATES
CENTRAL NERVOUS SYSTEM
COMPUTERIZED TOMOGRAPHY
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
EMISSION COMPUTED TOMOGRAPHY
ENCEPHALITIS
FLUORINE 18
FLUORINE ISOTOPES
GLUCOSE
GROWTH FACTORS
HEXOSES
HOURS LIVING RADIOISOTOPES
IMAGE PROCESSING
INFECTIOUS DISEASES
INTERFERON
ISOTOPES
LIGHT NUCLEI
LYMPHOKINES
METABOLISM
MITOGENS
MONOSACCHARIDES
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NMR IMAGING
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANS
POSITRON COMPUTED TOMOGRAPHY
PROCESSING
PROTEINS
RADIOISOTOPES
SACCHARIDES
TOMOGRAPHY
VIRAL DISEASES
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ALDEHYDES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
BRAIN
CARBOHYDRATES
CENTRAL NERVOUS SYSTEM
COMPUTERIZED TOMOGRAPHY
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
EMISSION COMPUTED TOMOGRAPHY
ENCEPHALITIS
FLUORINE 18
FLUORINE ISOTOPES
GLUCOSE
GROWTH FACTORS
HEXOSES
HOURS LIVING RADIOISOTOPES
IMAGE PROCESSING
INFECTIOUS DISEASES
INTERFERON
ISOTOPES
LIGHT NUCLEI
LYMPHOKINES
METABOLISM
MITOGENS
MONOSACCHARIDES
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NMR IMAGING
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANS
POSITRON COMPUTED TOMOGRAPHY
PROCESSING
PROTEINS
RADIOISOTOPES
SACCHARIDES
TOMOGRAPHY
VIRAL DISEASES